BLUEPRINT MEDICINES CORP's ticker is BPMC and the CUSIP is 09627Y109. A total of 238 filers reported holding BLUEPRINT MEDICINES CORP in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $348,000 | +6860.0% | 5,280 | +4881.1% | 0.01% | – |
Q2 2022 | $5,000 | -97.6% | 106 | -96.8% | 0.00% | -100.0% |
Q1 2022 | $212,000 | +161.7% | 3,313 | +321.5% | 0.01% | +133.3% |
Q3 2021 | $81,000 | +72.3% | 786 | +55.3% | 0.00% | -40.0% |
Q3 2020 | $47,000 | +683.3% | 506 | +612.7% | 0.01% | +400.0% |
Q2 2020 | $6,000 | -76.0% | 71 | -83.2% | 0.00% | -90.9% |
Q1 2020 | $25,000 | -75.5% | 423 | -69.4% | 0.01% | -62.1% |
Q3 2019 | $102,000 | +200.0% | 1,384 | +217.4% | 0.03% | +141.7% |
Q3 2018 | $34,000 | – | 436 | +43500.0% | 0.01% | – |
Q4 2017 | $0 | -100.0% | 1 | -99.7% | 0.00% | -100.0% |
Q3 2017 | $26,000 | -65.3% | 367 | -80.5% | 0.02% | -81.6% |
Q1 2017 | $75,000 | – | 1,886 | – | 0.10% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aquilo Capital Management, LLC | 716,539 | $36,192,000 | 12.35% |
CADIAN CAPITAL MANAGEMENT, LP | 2,020,629 | $102,062,000 | 6.89% |
Casdin Capital, LLC | 1,150,000 | $58,087,000 | 4.91% |
DAFNA Capital Management LLC | 261,280 | $13,197,000 | 3.60% |
Nextech Invest Ltd. | 188,228 | $9,507,000 | 3.21% |
Eagle Health Investments LP | 170,551 | $8,615,000 | 2.01% |
Boxer Capital, LLC | 507,374 | $25,627,000 | 1.62% |
Rock Springs Capital Management LP | 979,174 | $49,458,000 | 1.44% |
EFG Asset Management (North America) Corp. | 130,454 | $6,589,000 | 1.39% |
Integral Health Asset Management, LLC | 130,000 | $6,566,000 | 1.35% |